Fujii Tatsuya, Wada-Hiraike Osamu, Nagamatsu Takeshi, Harada Miyuki, Hirata Tetsuya, Koga Kaori, Fujii Tomoyuki, Osuga Yutaka
Department of Obstetrics and Gynecology, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113 8655, Japan.
Reprod Biol Endocrinol. 2016 Nov 3;14(1):73. doi: 10.1186/s12958-016-0209-2.
Endometriosis has been shown to be associated with second- to third-trimester pregnancy complications such as preterm birth and placenta previa, but the evidence is inconsistent. We hypothesized that endometriosis severity might affect these inconsistent results. Therefore we aimed to conduct a retrospective cohort study to elucidate whether endometriosis severity is associated with the incidence rates of adverse pregnancy outcomes.
The patients who achieved singleton pregnancy by assisted reproductive technology (ART) in our facility between March 2000 and December 2014 (N = 631) were included in this analysis. Among them, 92 women demonstrated surgically proven endometriosis, and 512 women were shown to not have endometriosis as a complication. Among the 92 cases of endometriosis, 10 were classified as revised American Society for Reproductive Medicine (rASRM) stage I and II, 31 cases were rASRM stage III, and 43 cases were rASRM stage IV; in 8 cases, the rASRM stage was unavailable. Logistic regression analysis was performed to calculate odds ratios (OR) and 95 % confidence interval (CI) for the rates of preterm birth, placenta previa, and small for gestational age. OR were adjusted by age, parity and the number of transferred embryos.
First we confirmed the frequency of preterm birth and placenta previa were significantly increased in women with endometriosis (preterm birth OR, 2.08; 95 % CI, 1.07-3.89, placenta previa OR, 15.1; 95 % CI, 4.40-61.7), while the frequency of small for gestational age was not. Moreover, we found the frequencies of preterm birth and placenta previa were significantly increased in women with rASRM stage IV endometriosis compared to other two groups: women with rASRM stage I-III endometriosis (preterm birth OR, 7.40; 95 % CI, 1.83-50.3; placenta previa OR, 11.0; 95 % CI, 1.75-216.5) and women without endometriosis (preterm birth adjusted OR, 4.11; 95 % CI, 1.88-8.55; placenta previa adjusted OR, 39.8; 95 % CI, 10.1-189.1). There were no significant difference between women with rASRM I-III endometriosis and women without endometriosis.
We found that the frequencies of preterm birth and placenta previa were significantly increased in women with endometriosis, and the severity of endometriosis might have an adverse impact on ART pregnancy.
子宫内膜异位症已被证明与孕中期至孕晚期的妊娠并发症有关,如早产和前置胎盘,但证据并不一致。我们推测子宫内膜异位症的严重程度可能会影响这些不一致的结果。因此,我们旨在进行一项回顾性队列研究,以阐明子宫内膜异位症的严重程度是否与不良妊娠结局的发生率相关。
本分析纳入了2000年3月至2014年12月期间在我们机构通过辅助生殖技术(ART)实现单胎妊娠的患者(N = 631)。其中,92名女性经手术证实患有子宫内膜异位症,512名女性未出现子宫内膜异位症并发症。在92例子宫内膜异位症病例中,10例被分类为美国生殖医学学会修订版(rASRM)I期和II期,31例为rASRM III期,43例为rASRM IV期;8例无法确定rASRM分期。进行逻辑回归分析,计算早产、前置胎盘和小于胎龄儿发生率的比值比(OR)和95%置信区间(CI)。OR根据年龄、产次和移植胚胎数量进行调整。
首先,我们证实子宫内膜异位症女性的早产和前置胎盘发生率显著增加(早产OR,2.08;95%CI,1.07 - 3.89;前置胎盘OR,15.1;95%CI,4.40 - 61.7),而小于胎龄儿的发生率没有增加。此外,我们发现与其他两组相比,rASRM IV期子宫内膜异位症女性的早产和前置胎盘发生率显著增加:rASRM I - III期子宫内膜异位症女性(早产OR,7.40;95%CI,1.83 - 50.3;前置胎盘OR,11.0;95%CI,1.75 - 216.5)和无子宫内膜异位症女性(调整后早产OR,4.11;95%CI,1.88 - 8.55;调整后前置胎盘OR,39.8;95%CI,10.1 - 189.1)。rASRM I - III期子宫内膜异位症女性和无子宫内膜异位症女性之间没有显著差异。
我们发现子宫内膜异位症女性的早产和前置胎盘发生率显著增加,子宫内膜异位症的严重程度可能对ART妊娠产生不利影响。